US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. December 01, 2022

    Top Opioid Target Kroger Inks $85M Deal, With $25M For Attys

    Supermarket giant Kroger is paying $85 million, including $25 million for plaintiff lawyers, to end opioid crisis lawsuits in New Mexico, according to settlement papers released Thursday, a relatively sizable sum that underscores the company's new status as a top target in nationwide opioid litigation. 

  2. November 23, 2022

    5 Years In, Opioid Attys Talk Historic Saga's Progress & Future

    Sprawling opioid litigation has unearthed pharmaceutical industry failures, altered attitudes about addiction and secured billions of dollars that are raising hopes that a bleak drug crisis in U.S. communities will eventually yield to brighter days, plaintiffs counsel told Law360 in a conversation about the five-year legal saga's progress — and its uncertain path forward.

  3. November 15, 2022

    Walmart Confirms $3B Deal Over Pharmacies' Opioid Sales

    Walmart officially revealed a $3.1 billion offer Tuesday aimed at ending thousands of lawsuits accusing its nationwide pharmacy network of fueling America's deadly crisis of opioid abuse, echoing similar settlements involving CVS Pharmacy and Walgreens.

  4. November 14, 2022

    6th Circ. Allows Opioid Judge's 'Unusual' Bellwether Approach

    An Ohio federal judge's policy of permitting local governments to overhaul bellwether complaints in multidistrict opioid litigation without facing a firm cutoff date is "unconventional" and "unusual" but not unacceptable, the Sixth Circuit ruled, rebuffing a large pharmacy chain's challenge.

  5. November 09, 2022

    Walgreens Faces $10B Opioid Trial Threat Despite $5B Deal

    New Mexico and Walgreens have submitted written closing arguments in the Land of Enchantment's opioid trial, and the state said it wants nearly $10 billion in damages — twice as much as Walgreens offered last week to settle opioid litigation across the entire country.

  6. November 04, 2022

    SF-Walgreens Opioid Trial Called Off Amid Settlement Talks

    Just days after Walgreens announced its $5 billion tentative settlement of nationwide opioid litigation, a California federal judge called off Monday's remedies trial in connection with an August decision that found the pharmacy giant liable for San Francisco's struggles with rampant opioid abuse.

  7. November 02, 2022

    After Pharmacy Deals, New Opioid Sellers In Legal 'Bull's-Eye'

    Multibillion-dollar settlements with top pharmacy retailers will shift a historic barrage of opioid litigation away from the last of its early targets and toward groups of pharmaceutical sellers and advisers whose business practices and legal defenses have received little attention, according to plaintiffs counsel and court records.

  8. November 02, 2022

    CVS, Walgreens Offer $10B To End Nationwide Opioid Suits

    CVS Pharmacy and Walgreens, the nation's two largest drugstore retailers, have preliminarily struck deals worth $10 billion to end thousands of lawsuits targeting their sales of prescription narcotics, the corporations and plaintiffs counsel said Wednesday.

  9. October 27, 2022

    Walgreens Says It'll Fight SF Estimate 40K Hooked On Opioids

    Walgreens will challenge a California federal judge's estimate that 40,000 San Franciscans suffered from opioid addiction, the retailer told the judge on Thursday ahead of a trial to determine what damages it owes for fueling the crisis, saying the number matters because the city wants it to pay billions for treatment.

  10. October 26, 2022

    SF Details $8B Opioid Plan As Walgreens Remedy Trial Looms

    San Francisco deserves $8 billion from Walgreens to alleviate the opioid epidemic's "calamitous effects," but it expects less money because the company created a problem it "cannot afford to fix," the city said Wednesday ahead of an imminent damages trial.